ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 91,100
-2,000 (-2.15%)
Jun 12, 2026, 3:30 PM KST
ABL Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -24,136 | -37,806 | -55,529 | -2,647 | 3,209 | -43,558 |
Depreciation & Amortization | 3,860 | 3,449 | 2,410 | 2,590 | 2,325 | 2,158 |
Loss (Gain) From Sale of Assets | 8.41 | 8.52 | 7.03 | 2.64 | -48 | 5.83 |
Loss (Gain) From Sale of Investments | -375.14 | -384.69 | -391.27 | -1,132 | 592.13 | -6,666 |
Stock-Based Compensation | 6,479 | 5,437 | 2,889 | 6,001 | 4,382 | 7,521 |
Provision & Write-off of Bad Debts | - | - | - | - | - | -682.58 |
Other Operating Activities | -1,701 | -85.45 | 2,004 | -203.88 | 1,352 | -15.18 |
Change in Accounts Receivable | - | -59,112 | - | - | - | - |
Change in Unearned Revenue | 53,339 | 53,339 | -25,976 | -31,859 | 63,562 | -3,160 |
Change in Other Net Operating Assets | -17,520 | -6,099 | 5,184 | -1,113 | -3,242 | 3,792 |
Operating Cash Flow | 19,955 | -41,253 | -69,403 | -28,362 | 72,132 | -40,605 |
Capital Expenditures | -13,276 | -20,065 | -9,023 | -5,740 | -2,055 | -1,244 |
Sale of Property, Plant & Equipment | 36.74 | 35.65 | 12.78 | 7.46 | 74.51 | 12 |
Cash Acquisitions | - | - | - | - | -21,256 | - |
Sale (Purchase) of Intangibles | -245.48 | -605.69 | -34.75 | -104.41 | -330.07 | -21.4 |
Sale (Purchase) of Real Estate | - | - | - | - | -1,252 | - |
Investment in Securities | 82,810 | 81,796 | -38,152 | 35,941 | -46,234 | 21,458 |
Other Investing Activities | 852.75 | 752.77 | 22.43 | -20.49 | -196.46 | 17.62 |
Investing Cash Flow | 70,378 | 62,113 | -47,174 | 29,884 | -71,250 | 20,221 |
Long-Term Debt Issued | - | 12,000 | - | 44,831 | - | - |
Long-Term Debt Repaid | - | -675.94 | -1,278 | -43,130 | -1,091 | -959.45 |
Net Debt Issued (Repaid) | 11,613 | 11,324 | -1,278 | 1,701 | -1,091 | -959.45 |
Issuance of Common Stock | 55,130 | 21,221 | 145,857 | 1,717 | 5,753 | 1,256 |
Other Financing Activities | -46.21 | -26.18 | -7.39 | -1,981 | -11.67 | -12.36 |
Financing Cash Flow | 66,697 | 32,519 | 144,572 | 1,437 | 4,649 | 284.13 |
Foreign Exchange Rate Adjustments | 6,474 | 2,314 | 229.74 | -29.86 | -1,984 | 1,030 |
Net Cash Flow | 163,504 | 55,693 | 28,225 | 2,929 | 3,547 | -19,070 |
Free Cash Flow | 6,679 | -61,318 | -78,426 | -34,102 | 70,076 | -41,850 |
Free Cash Flow Margin | 7.40% | -77.28% | -234.79% | -52.03% | 104.12% | -784.87% |
Free Cash Flow Per Share | 125.34 | -1190.60 | -1633.14 | -712.77 | 1473.23 | -890.99 |
Cash Interest Paid | 1,543 | 1,132 | 165.07 | 2,521 | 1,205 | - |
Cash Income Tax Paid | 123.67 | 112.89 | -1,346 | 1,621 | -2.6 | -75.7 |
Levered Free Cash Flow | 7,280 | -52,541 | -62,856 | -37,710 | 63,171 | - |
Unlevered Free Cash Flow | 8,159 | -51,920 | -62,833 | -36,365 | 64,000 | - |
Change in Working Capital | 35,819 | -11,871 | -20,792 | -32,972 | 60,320 | 631.38 |